Nothing Special   »   [go: up one dir, main page]

AT255421B - Verfahren zur Herstellung von neuen Pyrimidinderivaten - Google Patents

Verfahren zur Herstellung von neuen Pyrimidinderivaten

Info

Publication number
AT255421B
AT255421B AT979464A AT979464A AT255421B AT 255421 B AT255421 B AT 255421B AT 979464 A AT979464 A AT 979464A AT 979464 A AT979464 A AT 979464A AT 255421 B AT255421 B AT 255421B
Authority
AT
Austria
Prior art keywords
preparation
pyrimidine derivatives
new pyrimidine
new
derivatives
Prior art date
Application number
AT979464A
Other languages
English (en)
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Application granted granted Critical
Publication of AT255421B publication Critical patent/AT255421B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT979464A 1963-11-19 1964-11-19 Verfahren zur Herstellung von neuen Pyrimidinderivaten AT255421B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45685/63A GB1101425A (en) 1963-11-19 1963-11-19 New pyrimidine derivatives

Publications (1)

Publication Number Publication Date
AT255421B true AT255421B (de) 1967-07-10

Family

ID=10438157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT979464A AT255421B (de) 1963-11-19 1964-11-19 Verfahren zur Herstellung von neuen Pyrimidinderivaten

Country Status (14)

Country Link
US (1) US3299067A (de)
AT (1) AT255421B (de)
BE (1) BE655431A (de)
BR (1) BR6464358D0 (de)
CH (1) CH437310A (de)
DE (1) DE1297610B (de)
DK (1) DK115995B (de)
ES (1) ES306226A1 (de)
FI (1) FI46163C (de)
FR (1) FR4770M (de)
GB (1) GB1101425A (de)
NL (2) NL6413349A (de)
NO (1) NO115800B (de)
SE (1) SE322521B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine
GB1369379A (en) * 1972-04-07 1974-10-09 Science Union & Cie Benzodioxole derivatives and processes for preparing them
US3919230A (en) * 1974-02-07 1975-11-11 Smithkline Corp {62 -Naphthylmethyl piperazinyl derivatives
US3988457A (en) * 1974-02-07 1976-10-26 Smithkline Corporation Novel compounds and compositions for treating Parkinson's disease
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
OA06083A (fr) * 1977-11-09 1981-06-30 Science Union & Cie Ste Franca Nouvelles pipérazines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
FR2519986A1 (fr) * 1982-01-21 1983-07-22 Adir Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2539990A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Composition pharmaceutique a action psychotrope dopaminergique contenant une 2-piperazinopyrimidine
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US4980350A (en) * 1988-02-25 1990-12-25 Merck & Co., Inc. Piperazinylalkylpyrimidines as hypoglycemic agents
EP0330263A1 (de) * 1988-02-25 1989-08-30 Merck & Co. Inc. Piperazinylalkylpyrimidine als hypoglycemische Mittel
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5859246A (en) 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
JP3687899B2 (ja) * 1997-09-29 2005-08-24 アベンティス・ファーマスーティカルズ・インコーポレイテツド アミノアルキルフェノール誘導体および関連化合物
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
KR20060133552A (ko) * 2004-01-16 2006-12-26 노파르티스 아게 2,4-디아미노피리미딘 및 심장근육발생 유도를 위한 그의용도
US7241891B2 (en) * 2004-03-29 2007-07-10 Chung-Shan Institute Of Science & Technology Method for the purification of Piribedil
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN101735201B (zh) * 2009-12-17 2012-05-30 宁夏康亚药业有限公司 一种吡贝地尔的制备方法
CN101830891A (zh) * 2010-05-18 2010-09-15 沈阳药科大学 一种吡贝地尔的制备方法
RU2618628C1 (ru) 2013-04-17 2017-05-05 Пфайзер Инк. Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
MA53944A (fr) 2014-08-28 2021-08-25 Asceneuron Sa Inhibiteurs de la glycosidase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2018010301A (es) 2016-02-25 2019-05-20 Asceneuron S A Sales de derivados de piperazina obtenidas por adicion de acidos.
MX2018010192A (es) 2016-02-25 2019-01-31 Asceneuron S A Inhibidores de glucosidasa.
WO2018153507A1 (en) 2017-02-24 2018-08-30 Asceneuron S.A. Substituted dihydrobenzofuran glycosidase inhibitors
MX2018010191A (es) 2016-02-25 2019-05-20 Asceneuron S A Inhibidores de glucosidasa.
US11261183B2 (en) 2016-02-25 2022-03-01 Asceneuron Sa Sulfoximine glycosidase inhibitors
CN106432212B (zh) * 2016-09-21 2019-01-11 苏州弘森药业股份有限公司 一种合成吡贝地尔的方法
CN107216318A (zh) * 2017-06-19 2017-09-29 太仓弘杉环保科技有限公司 一种吡贝地尔制备方法
CN107266429A (zh) * 2017-06-19 2017-10-20 太仓大唐化纤厂 一种高品质的吡贝地尔制备方法
CN107163032A (zh) * 2017-06-19 2017-09-15 太仓卡斯特姆新材料有限公司 一种高收率的吡贝地尔制备方法
CN107417674B (zh) * 2017-06-26 2020-12-29 苏州弘森药业股份有限公司 一种吡贝地尔的提纯方法
WO2019037860A1 (en) 2017-08-24 2019-02-28 Asceneuron S.A. LINEAR INHIBITORS OF GLYCOSIDASE
WO2019037861A1 (en) 2017-08-24 2019-02-28 Asceneuron S.A. ANNOTATED GLYCOSIDASE INHIBITORS
RU2737721C2 (ru) * 2017-12-15 2020-12-02 Алексей Георгиевич Александров Способ получения фармацевтической субстанции на основе пирибедила
WO2020039028A1 (en) 2018-08-22 2020-02-27 Asceneuron S. A. Tetrahydro-benzoazepine glycosidase inhibitors
WO2020039029A1 (en) 2018-08-22 2020-02-27 Asceneuron S. A. Spiro compounds as glycosidase inhibitors
WO2020039027A1 (en) 2018-08-22 2020-02-27 Asceneuron S. A. Pyrrolidine glycosidase inhibitors
EA202190275A1 (ru) 2018-08-22 2021-08-02 Асенейрон С. А. Сукцинатные и фумаратные кислотно-аддитивные соли производных пиперазина, пригодные в качестве ингибиторов гликозидазы
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof
WO2020169804A1 (en) 2019-02-22 2020-08-27 Asceneuron Sa Fused glycosidase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE485737A (de) * 1947-11-12
DE942029C (de) * 1951-06-22 1956-04-26 American Cyanamid Co Verfahren zur Herstellung von neuen, in 1-Stellung substituierten 4-Aminopiperazinderivaten
US3078214A (en) * 1958-09-12 1963-02-19 Sandoz Ag Treatment of mental disturbances with esters of indoles
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US3141820A (en) * 1960-10-31 1964-07-21 Merck & Co Inc Coccidiosis control composition
BE618035A (de) * 1961-05-26
US3144387A (en) * 1961-06-30 1964-08-11 Parke Davis & Co Anti-inflammatory compositions

Also Published As

Publication number Publication date
BE655431A (de) 1965-05-06
NL6413349A (de) 1965-05-20
US3299067A (en) 1967-01-17
FR4770M (de) 1967-01-23
NL127996C (de)
NO115800B (de) 1968-12-09
ES306226A1 (es) 1965-03-01
FI46163C (fi) 1973-01-10
FI46163B (de) 1972-10-02
BR6464358D0 (pt) 1973-07-26
SE322521B (de) 1970-04-13
CH437310A (fr) 1967-06-15
GB1101425A (en) 1968-01-31
DE1297610B (de) 1969-06-19
DK115995B (da) 1969-12-01

Similar Documents

Publication Publication Date Title
AT255421B (de) Verfahren zur Herstellung von neuen Pyrimidinderivaten
AT269174B (de) Verfahren zur Herstellung von neuen Hydroxyalkyldextranen
CH456608A (de) Verfahren zur Herstellung von Pyrimidinderivaten
AT252458B (de) Verfahren zur Herstellung von neuen 1-Glykosyl-5-azacytosinen
CH436290A (de) Verfahren zur Herstellung von neuen 4-Amino-piperidinen
CH451200A (de) Verfahren zur Herstellung von neuen Bis-alkanolaminderivaten
AT266812B (de) Verfahren zur Herstellung von neuen Phenylcyclopropancarbonsäureamiden
CH460800A (de) Verfahren zur Herstellung von neuen 2-Amino-5-halogen-benzylaminen
CH451201A (de) Verfahren zur Herstellung von neuen Phenylalkanolaminderivaten
AT242698B (de) Verfahren zur Herstellung von neuen 3-Sulfanilamidoisoxazolen
AT246147B (de) Verfahren zur Herstellung von neuen o-Hydroxyphenyl-s-triazinen
AT240376B (de) Verfahren zur Herstellung von neuen 4-Aza-thioxanthen-Derivaten
AT246150B (de) Verfahren zur Herstellung von neuen o-Hydroxyphenyl-s-triazinen
AT258920B (de) Verfahren zur Herstellung von neuen substituierten Piperazinderivaten
AT246155B (de) Verfahren zur Herstellung von neuen Pyridazoniminen
CH448094A (de) Verfahren zur Herstellung von neuen 2-Nitroaniliden
AT247312B (de) Verfahren zur Herstellung von neuen α-Methyl-α-phenyl-β-äthylsuccinimids
AT246149B (de) Verfahren zur Herstellung von neuen o-Hydroxyphenyl-s-triazinen
AT243803B (de) Verfahren zur Herstellung von neuen 4-Carboxyalkylmercapto-5-arylpyrimidinen
AT254190B (de) Verfahren zur Herstellung von neuen Chinolinderivaten
AT246131B (de) Verfahren zur Herstellung von neuen 5-Hydrazino-pyrazol-Derivaten
AT246148B (de) Verfahren zur Herstellung von neuen o-Hydroxyphenyl-s-triazinen
CH457418A (de) Verfahren zur Herstellung von neuen 17B-Acetoacetoxysteroiden
AT250962B (de) Verfahren zur Herstellung von neuen Tetrahydroisochinolinderivaten
CH424779A (de) Verfahren zur Herstellung von neuen Hydrazin-Derivaten